Background-Tissue factor pathway inhibitor (TFPI) is a physiological antagonist of TF. We tested whether a brief irrigation with TFPI protein (rTFPI) or TFPI gene transfer into injured arteries would suppress TF activity and reduce fibroproliferative changes and investigated whether a combination of these methods would show an additive effect. Methods and Results-We prepared adenoviruses expressing either TFPI (AdTFPI) or bacterial -galactosidase (AdLacZ). Rabbit carotid arteries were balloon-injured and either infected with AdTFPI (or AdLacZ) or irrigated briefly with rTFPI (or saline). After injury, TF activity in arteries increased and was sustained; however, it was suppressed during the initial 24 hours by rTFPI irrigation (but not by gene transfer) and for a substantial period of time by TFPI gene transfer (but not by rTFPI irrigation). Four weeks later, the ratio of the intimal to medial areas was 34.3Ϯ8.7% (meanϮSD, nϭ14) in saline-treated arteries and 33.3Ϯ4.2% in AdLacZ-infected arteries (PϭNS versus saline). However, it was reduced to 25.5Ϯ8.5% in rTFPI-irrigated arteries (PϽ0.01 versus saline) and to 20. Key Words: anticoagulants Ⅲ gene therapy Ⅲ platelets Ⅲ thrombin Ⅲ thrombus T issue factor (TF), a 47-kDa transmembrane glycoprotein, binds and activates factor VII, which then activates factors IX and X, thus initiating the blood coagulation pathway, 1,2 leading to generation of thrombin. Thrombin is an inducer of fibrin formation and also a potent mitogen for the cells of the arterial wall. 3 In normal arteries, TF is expressed only in the adventitia. 4 In atherosclerotic arteries, however, it is expressed ubiquitously in the plaques. 5,6 Furthermore, once injury occurs, TF becomes expressed within hours in almost all layers of the arterial wall. 7,8 Accumulating evidence suggests that TF may have a variety of actions in addition to initiating thrombin formation. For example, TF VIIa induces the activation of mitogen-activated protein kinase 9 and evokes intracellular Ca 2ϩ mobilization, 10 which may lead to cell proliferation. The finding that TF expression in the neointima is sustained for 8 weeks after injury 11 and a report that thrombin activity in arteries is detectable for 2 weeks after balloon injury 12 both suggest that TF and thrombin may be involved in the proliferative response after arterial injury and that anti-TF treatment could be effective not only in inhibiting thrombus formation but also in suppressing neointima formation.Intact endothelial cells produce an anti-TF molecule, known as tissue factor pathway inhibitor (TFPI). TFPI, a Kunitz-type protease inhibitor, directly inhibits the factor Xa and the factor VIIa/TF catalytic complex. 13,14 Because TF is an initiator of the coagulation cascade, we expected that TFPI would be a more effective molecule against thrombin than a direct thrombin antagonist such as hirudin.It has been shown repeatedly that adenovirus-mediated gene transfer into arteries can evoke site-specific production We first investigated whether local delivery of T...